Annual Report 2017
Five top scientific advances
And the architecture project winner is…
Editorials from our Directors
Leading Clinical Trials
  • Home
  • Organization Chart
  • Research Areas
  • Facts and Figures
  • Highlights
  • Pdf Version
MENU

VHIR has signed an agreement with Probitas and an Angolan Hospital to investigate drug-resistant tuberculosis

September 8, 2014 11:56 am Published by ondeuev

Categorised in:

This post was written by ondeuev

Archives

Categories

  • No categories

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
VHIR Annual Report 2017

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy. Read more | I agree

© FIR-HUVH Fundació Institut de Recerca Hospital Universitari Vall d’Hebron 2017 | Developed by: ondeuev